Key Highlights
- Dr. Joseph Knight named CEO of Simpson Interventions, Inc.
- Founder Dr. John B. Simpson remains as Chairman and assumes Chief Medical Officer role.
- Dr. Knight brings extensive academic and professional experience in cardiovascular technologies.
- Transition effective from May 1st, 2024.
Source: Business Wire
Notable Quotes
- “I’m thrilled to take the leadership mantle from Dr. Simpson, who has been a luminary in the field of cardiovascular medicine for generations. Not only has Dr. Simpson grown Simpson Interventions into a company at the forefront of breakthroughs in interventional cardiology (IC), but he’s also had the foresight to tackle the complex problems that have plagued the interventional cardiology community for decades.” — Dr. Joseph Knight, Chief Executive Officer (CEO) at Simpson Interventions, Inc
- “I’ve always believed my strength lies in taking a company from the ‘device drawing on a napkin’ phase to the ‘First in Human’ phase. Now that we have reached this critical milestone, it is the perfect time to bring in a leader with the operational expertise to guide us through the next stages of growth.” — Dr. John B. Simpson, Chairman of the Board of Directors and Chief Medical Officer (CMO) at Simpson Interventions, Inc
SoHC's Take
The appointment of Dr. Joseph Knight as CEO marks a significant transition for Simpson Interventions, Inc. Dr. Knight’s impressive academic background and his extensive experience in leading medical technology companies position him well to drive Simpson Interventions forward. The continued involvement of Dr. John B. Simpson as Chairman and Chief Medical Officer ensures that the company retains its innovative edge while benefiting from Dr. Knight’s operational expertise. This strategic leadership change is poised to further cement Simpson Interventions’ status as a leader in cardiovascular interventional devices.
